These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32755599)

  • 1. Biolayer Interferometry-based FcγRIIa binding assay for a therapeutic antibody with strong effector function.
    Bajardi-Taccioli A; Co C; Bond C; Masci A; Brantley T; Xu C; Bergelson S; Feschenko M
    Anal Biochem; 2020 Dec; 611():113842. PubMed ID: 32755599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of protein aggregates on characterization of FcRn binding of Fc-fusion therapeutics.
    Bajardi-Taccioli A; Blum A; Xu C; Sosic Z; Bergelson S; Feschenko M
    Mol Immunol; 2015 Oct; 67(2 Pt B):616-24. PubMed ID: 26254986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural network-based fingerprinting of monoclonal antibody aggregation using biolayer interferometry.
    Budholiya N; Roy S; Rathore AS
    Anal Bioanal Chem; 2020 Apr; 412(9):2177-2186. PubMed ID: 31620826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life.
    Souders CA; Nelson SC; Wang Y; Crowley AR; Klempner MS; Thomas W
    MAbs; 2015; 7(5):912-21. PubMed ID: 26018774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential influence on antibody dependent cellular phagocytosis by different glycoforms on therapeutic Monoclonal antibodies.
    Kuhns S; Shu J; Xiang C; Guzman R; Zhang Q; Bretzlaff W; Miscalichi N; Kalenian K; Joubert M
    J Biotechnol; 2020 Jun; 317():5-15. PubMed ID: 32361021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of a GroEL-BLI Biosensor to Rapidly Assess Preaggregate Populations for Antibody Solutions Exhibiting Different Stability Profiles.
    Pace SE; Joshi SB; Esfandiary R; Stadelman R; Bishop SM; Middaugh CR; Fisher MT; Volkin DB
    J Pharm Sci; 2018 Feb; 107(2):559-570. PubMed ID: 29037466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors.
    Goulet DR; Zwolak A; Williams JA; Chiu ML; Atkins WM
    Proteins; 2020 May; 88(5):689-697. PubMed ID: 31702857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
    PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and applications of AlphaScreen-based FcRn binding assay to characterize monoclonal antibodies.
    Wu Q; Lee HY; Wong PY; Jiang G; Gazzano-Santoro H
    J Immunol Methods; 2015 May; 420():31-7. PubMed ID: 25837414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A.
    Capkin E; Kurt H; Gurel B; Bicak D; Akgun Bas S; Daglikoca DE; Yuce M
    Langmuir; 2022 Dec; 38(48):14623-14634. PubMed ID: 36416530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of IgG2 high molecular weight species on neonatal Fc receptor binding assays.
    Zhang Y; Mathur A; Maher G; Arroll T; Bailey R
    Anal Biochem; 2015 Nov; 489():25-31. PubMed ID: 26255698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free kinetic analysis of an antibody-antigen interaction using biolayer interferometry.
    Kumaraswamy S; Tobias R
    Methods Mol Biol; 2015; 1278():165-82. PubMed ID: 25859949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening of IgG quality attributes - effects on Fc receptor binding.
    Geuijen KPM; Oppers-Tiemissen C; Egging DF; Simons PJ; Boon L; Schasfoort RBM; Eppink MHM
    FEBS Open Bio; 2017 Oct; 7(10):1557-1574. PubMed ID: 28979843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly parallel characterization of IgG Fc binding interactions.
    Boesch AW; Brown EP; Cheng HD; Ofori MO; Normandin E; Nigrovic PA; Alter G; Ackerman ME
    MAbs; 2014; 6(4):915-27. PubMed ID: 24927273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody.
    Choi JR; Kim MJ; Tae N; Wi TM; Kim SH; Lee ES; Kim DH
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32630442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the effects of macromolecular crowding on antibody function with biolayer interferometry.
    Kim DM; Yao X; Vanam RP; Marlow MS
    MAbs; 2019 Oct; 11(7):1319-1330. PubMed ID: 31401928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different immunoassay methods to detect human anti-drug antibody using the WHO erythropoietin antibody reference panel for analytes.
    Shibata H; Nishimura K; Miyama C; Tada M; Suzuki T; Saito Y; Ishii-Watabe A
    J Immunol Methods; 2018 Jan; 452():73-77. PubMed ID: 28970009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.